Myeloproliferative Diseases Flashcards

1
Q

What are myeloproliferative diseases characterized by?

A

Clonal proliferation of myeloid haemopoietic cells in the bone marrow

Myeloproliferative diseases are a group of disorders characterized by the overproduction of blood cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the three main types of myeloproliferative diseases.

A
  • Polycythaemia vera (PV)
  • Essential thrombocytosis (ET)
  • Primary myelofibrosis (MF)

These diseases are closely related and can evolve from one form to another.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the key genes involved in myeloproliferative diseases?

A
  • JAK2
  • MPL
  • CALR

These genes are associated with acquired mutations that lead to these diseases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What mutation is commonly associated with Polycythaemia vera?

A

JAK2V617F mutation

This mutation is present in about 97% of patients with Polycythaemia vera.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define primary polycythaemia.

A

Increase in haemoglobin concentration above the upper limit of normal for the patient’s age and sex

The red cell mass is greater than 125% of the expected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the cut-off values for diagnosing primary polycythaemia in men and women?

A
  • Hb greater than 185 g/L or haematocrit above 0.52 in men
  • Hb greater than 165 g/L or haematocrit above 0.48 in women

These values help distinguish primary polycythaemia from normal variations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the difference between absolute and relative polycythaemia?

A
  • Absolute polycythaemia: increased red cell mass
  • Relative polycythaemia: reduced plasma volume

Relative polycythaemia can cause a pseudo rise in packed cell volume.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some congenital causes of secondary polycythaemia?

A
  • Defects of the oxygen-sensing pathway
  • VHL gene mutation
  • PHD2 mutations
  • HIF-2α mutations

These genetic defects can lead to increased erythropoietin production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some acquired causes of secondary polycythaemia?

A
  • Tumours (e.g., cerebellar haemangioblastoma, renal cell cancer)
  • Drug-associated (e.g., erythropoietin administration)

Acquired causes can significantly influence erythropoietin levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the clinical features of Polycythaemia vera.

A
  • Hyperviscosity symptoms
  • Plethora
  • Splenomegaly
  • Thrombosis and bleeding
  • Gout and itching

These symptoms arise due to increased red cell mass and associated complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What laboratory findings are indicative of Polycythaemia vera?

A
  • JAK2 mutation
  • Hct >0.48 in female and >0.52 in male
  • Low erythropoietin
  • High LDH and uric acid
  • Neutrophil leukocytosis

These findings can assist in the diagnosis of the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the first-line treatment for Polycythaemia vera?

A
  • Venesection
  • Hydroxocarbamide (HU)
  • JAK inhibitors (e.g., ruxolitinib)
  • Interferon

Treatment aims to reduce symptoms and complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What characterizes Essential Thrombocythemia?

A

Sustained increase in platelet count due to megakaryocyte proliferation

Platelet count is greater than 450,000/cmm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the major diagnostic criteria for Essential Thrombocythemia?

A
  • Pathogenetic mutation (e.g. in JAK2 or CALR)
  • No other myeloid malignancy

Diagnosis requires specific criteria to rule out other conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are common findings in patients with Essential Thrombocythemia?

A
  • Asymptomatic
  • Thrombosis
  • Bleeding
  • Splenomegaly
  • Erythromalgia
  • Giant platelets

These findings can vary significantly among patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the treatment for Essential Thrombocythemia?

A
  • Antiplatelets (e.g., aspirin, clopidogrel)
  • Hydroxocarbamide
  • Anagrelide
  • JAK2 inhibitors

Treatment is aimed at managing symptoms and reducing thrombotic risks.

17
Q

What is primary myelofibrosis?

A

Development of haemopoiesis in the spleen and liver

It leads to significant clinical symptoms and complications.

18
Q

What are the clinical features of primary myelofibrosis?

A
  • Anaemia
  • Massive splenomegaly
  • Hypermetabolic symptoms
  • Bleeding
  • Bone pain

These features arise from ineffective haemopoiesis and splenic involvement.

19
Q

What laboratory findings are associated with primary myelofibrosis?

A
  • Leucoerythroblastic features on PBF
  • Hypercellular marrow
  • High LDH and uric acid

Findings may indicate ineffective haemopoiesis.

20
Q

What is the median survival for patients with primary myelofibrosis?

A

About 5 years

Prognosis can vary based on individual circumstances.